195 related articles for article (PubMed ID: 16313234)
1. Pharmacogenomics and its potential impact on drug and formulation development.
Regnstrom K; Burgess DJ
Crit Rev Ther Drug Carrier Syst; 2005; 22(5):465-92. PubMed ID: 16313234
[TBL] [Abstract][Full Text] [Related]
2. The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).
Tremaine L; Brian W; DelMonte T; Francke S; Groenen P; Johnson K; Li L; Pearson K; Marshall JC
Pharmacogenomics; 2015 Dec; 16(18):2055-67. PubMed ID: 26616152
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop.
Lesko LJ; Salerno RA; Spear BB; Anderson DC; Anderson T; Brazell C; Collins J; Dorner A; Essayan D; Gomez-Mancilla B; Hackett J; Huang SM; Ide S; Killinger J; Leighton J; Mansfield E; Meyer R; Ryan SG; Schmith V; Shaw P; Sistare F; Watson M; Worobec A
J Clin Pharmacol; 2003 Apr; 43(4):342-58. PubMed ID: 12723455
[TBL] [Abstract][Full Text] [Related]
4. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective.
Lesko LJ; Woodcock J
Nat Rev Drug Discov; 2004 Sep; 3(9):763-9. PubMed ID: 15340386
[TBL] [Abstract][Full Text] [Related]
5. The regulation of pharmacogenomics-based drugs and policy making.
Issa AM
Curr Top Med Chem; 2004; 4(13):1455-60. PubMed ID: 15379657
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics. Going from genome to pill.
Service RF
Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
[No Abstract] [Full Text] [Related]
7. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
8. Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?".
Llerena A; Michel G; Jeannesson E; Wong S; Manolopoulos VG; Hockett RD; Boubekeur K; Siest G; Beaune P; Haefliger C; Arnold HP; Junien C; Petrovic N; Molloy R; Bekers O; Donnelly C; Arens HJ; Kaput J; McComb J
Clin Chem Lab Med; 2007; 45(7):843-50. PubMed ID: 17617025
[TBL] [Abstract][Full Text] [Related]
9. Progress in pharmacogenomics and its promise for medicine.
Blake CA; Sobel BE
Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
[TBL] [Abstract][Full Text] [Related]
11. Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems.
Gupta S; Jhawat V
J Control Release; 2017 Jan; 245():15-26. PubMed ID: 27871989
[TBL] [Abstract][Full Text] [Related]
12. Development and regulatory strategies for drug and diagnostic co-development.
Hinman LM; Carl KM; Spear BB; Salerno RA; Becker RL; Abbott BM; Kelly JF; Mansfield E; Katz RG; Harper C; Day SP; Pacanowski MA; Pignato W
Pharmacogenomics; 2010 Dec; 11(12):1669-75. PubMed ID: 21142909
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics and bioinformatics: PharmGKB.
Thorn CF; Klein TE; Altman RB
Pharmacogenomics; 2010 Apr; 11(4):501-5. PubMed ID: 20350130
[TBL] [Abstract][Full Text] [Related]
14. Biomedical informatics methods in pharmacogenomics.
Yan Q
Methods Mol Med; 2005; 108():459-86. PubMed ID: 16028700
[TBL] [Abstract][Full Text] [Related]
15. Microarrays in pharmacogenomics--advances and future promise.
Chicurel ME; Dalma-Weiszhausz DD
Pharmacogenomics; 2002 Sep; 3(5):589-601. PubMed ID: 12223046
[TBL] [Abstract][Full Text] [Related]
16. Personalized medicine and rescuing "unsafe" drugs with pharmacogenomics: a regulatory perspective.
Avery M
Food Drug Law J; 2010; 65(1):37-65, i-ii. PubMed ID: 24475534
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics: integration into drug discovery and development.
Johnson K; Thompson J; Power A
Curr Top Med Chem; 2005; 5(11):1039-46. PubMed ID: 16181129
[TBL] [Abstract][Full Text] [Related]
18. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
Yan Q
Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
[TBL] [Abstract][Full Text] [Related]
19. Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics.
Hardiman G
Pharmacogenomics; 2008 Jan; 9(1):5-9. PubMed ID: 18154443
[No Abstract] [Full Text] [Related]
20. The impact of genomics on anti-infectives drug discovery and development.
Parkinson T
Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
